학술논문

23P Design of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients.
Document Type
Article
Source
Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Subject
*THERAPEUTICS
*PROTEIN engineering
*BREAST cancer patients
*CANCER chemotherapy
Language
ISSN
0923-7534